https://www.avient.com/news/discover-sparkling-new-wilflex-special-effects-textile-printing-inks-polyone-iss-2017
The new offerings for 2017 include:
• Wilflex One™ Special Effects – additions of shimmers, glitter, particle base, phosphorescent and foil adhesive to this non-PVC range
• Wilflex™ Elements – a new tactile selection book featuring the primary EPIC™ ink technologies, colors and finishes
• Wilflex Originals – latest design number 9 featuring a 1961 Eldorado Cadillac, created to mark the Wilflex 55th Anniversary celebrated at the end of 2016
• Oasis™ Imagebrite Reflectives – This brand new water-based reflective ink, containing light reflecting microspheres, will be exclusively previewed at the show.
Photo Caption: Wilflex Originals Design n.9 - Cadillac
https://www.avient.com/news/non-pfas-flame-retardant-formulations-expand-avient-s-compl-t-long-fiber-polyketone-portfolio
December 9, 2024
CLEVELAND – December 9, 2024 – Avient Corporation, a premier provider of specialty and sustainable materials solutions and services, announces the addition of flame-retardant (FR) grades manufactured without intentionally added PFAS-based raw materials to its portfolio of Complēt™ PKE Long Fiber Reinforced Polyketone Thermoplastics.
https://www.avient.com/news/polyone-showcase-polymer-solutions-disinfectant-resistance-mdm-west-2016
February 9, 2016
PolyOne is exhibiting at MD&M West in Anaheim, California, in booth 848 from February 9 – 11, 2016.
https://www.avient.com/sites/default/files/2025-03/Q4 2024 Avient Webcast Slides w Non-GAAP.pdf
All Rights Reserved
2025
Color, Additives & Inks
E N D M A R K E T S R E G I O N S
34%
21%
15%
11%
9%
8%
Packaging
Telecom 1%Energy 1%
Transportation
Industrial
Consumer
34%
37%
20%
9%
US & Canada
Latin America
Asia
Europe, Middle East
and Africa
Healthcare
Building &
Construction
21Copyright © .
All Rights Reserved
2025
Specialty Engineered Materials
E N D M A R K E T S R E G I O N S
20%
17%
14%13%
9%
9%
7%
7%
4%
Defense
Packaging
Telecom
Building &
construction
Transportation
Industrial
Consumer
54%
33%
13%
US & Canada
Asia
Europe,
Middle East
and Africa
Energy
Healthcare
Copyright © .
All Rights Reserved
2025 22
Avient 2024 regional sales, by end market
U S & C AN AD A
41% of sales
E M E A
35% of sales
AS I A
18% of sales
L AT I N AM E R I C A
6% of sales
13%
22%
14%
9%
13%
10%
9%
6%
4%
Packaging TelecomEnergyDefenseHealthcareBuilding &
construction
TransportationIndustrialConsumer
26%
13%
16%
13%
10%
5%
10%
5%
2%
31%
26%
14%
10%
5%
10%
1% 1% 2%
61%
20%
7%
6%
4%
2%
Copyright © .
https://www.avient.com/sites/default/files/2021-09/avnt-q2-2021-earnings-presentation.pdf
D
is
t.
)
K
W
R
P
P
G
A
V
Y
F
U
L
R
P
M
G
C
P
H
X
L
F
M
C
H
U
N
IF
F
E
C
L
A
S
H
K
R
A
E
M
N
C
E
S
C
L
A
L
B
Median: 5%Median: 3%
Source: Peer data per Bloomberg market data as of July 28, 2021
Avient reflects 2021 estimated revenue of $4,650M and excludes one-time synergy capture CAPEX ($20M)
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
Free Cash Flow Conversion (1)
2021E (%)
Being asset light helps us to generate
strong free cash flow that is in line
with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA
Median: 81% Median: 78%
H I G H F R E E C A S H F L OW
C O N V E R S I O N
Avient reflects 2021 estimated EBITDA of $580M and excludes one-time synergy capture CAPEX ($20M)
Source: Peer data per Bloomberg market data as of July 28, 2021
87
90
86
82
80 78
73
87
82 82
79 79 78 78 77 76
71
67
46
A
vi
e
n
t
K
W
R
P
P
G
A
V
Y
F
U
L
R
P
M
G
C
P
F
M
C
U
N
V
R
C
E
IF
F
A
S
H
E
C
L
B
N
R
E
M
N
H
X
L
H
U
N
K
R
A
S
C
L
A
L
B
(6)
Source: Peer data per Bloomberg market data as of July 28, 2021
Total Enterprise Value / 2021E EBITDA
Our current valuation with updated
guidance implies an EBITDA multiple
that is below specialty formulator
peers and the median of other
selected chemical / specialty
companies.
With the Clariant Masterbatch
acquisition and divestment of the
PP&S business, our exposure is now
concentrated in less-cyclical and
high-growth markets, with increased
geographic diversification and a more
specialized portfolio that can
significantly expand EBITDA margins.
25
Avient reflects 2021 estimated EBITDA of $580M
O U R VA LUATI O N V E R S U S P E E R S
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
9.5
18.5
15.1 15.1
14.0
11.0 10.4
29.5
28.2
23.9
18.7
12.4 12.2
11.1
9.3 9.2 9.2
7.6 7.6
6.0
A
vi
e
n
t
K
W
R
P
P
G
A
V
Y
R
P
M
F
U
L
G
C
P
A
L
B
H
X
L
E
C
L
IF
F
F
M
C
B
N
R
A
S
H
S
C
L
E
M
N
U
N
V
R
K
R
A
C
E
H
U
N
Median: 11.1xMedian: 14.6x
S U M M A RY: W H Y I N V E S T I N AV I E N T ?
https://www.avient.com/sites/default/files/2020-10/tpe-overmold-design-guide.pdf
Radius at
Runner Transition
W
Ejector or "Sucker-pin"
"Cold Slug" = 1.5(W)
Figure 8.
Runner system with cold slug well.
3
12
4
6 7
8
9 10
1112
13
1415
16
5
2
3
4
5 6
7
8
9
10
11
12
1314
15
16
1
Figure 4.
Radius at
Runner Transition
W
Ejector or "Sucker-pin"
"Cold Slug" = 1.5(W)
Figure 8.
https://www.avient.com/news/archives?page=63
June 9, 2015
https://www.avient.com/investor-center/investor-news/archives?page=35
December 9, 2015
https://www.avient.com/investors/investor-news?page=7
Avient to Hold Webcast on February 9, 2021 to Review Fourth Quarter 2020 Results and 2021 Outlook...
https://www.avient.com/investor-center/investor-news/archives?page=12
February 9, 2021